Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Chromosomes, Human, Y | 14 | 2020 | 147 | 2.930 |
Why?
|
Lebanon | 38 | 2022 | 227 | 2.400 |
Why?
|
Haplotypes | 24 | 2020 | 2782 | 2.160 |
Why?
|
Genetics, Population | 21 | 2021 | 931 | 1.530 |
Why?
|
DNA, Mitochondrial | 10 | 2018 | 804 | 1.530 |
Why?
|
Emigration and Immigration | 7 | 2018 | 402 | 1.310 |
Why?
|
Coronary Artery Disease | 19 | 2023 | 6416 | 1.120 |
Why?
|
Cholesterol, HDL | 6 | 2024 | 1807 | 1.040 |
Why?
|
Polymorphism, Single Nucleotide | 31 | 2024 | 15500 | 0.980 |
Why?
|
Population | 3 | 2020 | 142 | 0.980 |
Why?
|
Gene Flow | 7 | 2019 | 79 | 0.920 |
Why?
|
Refugees | 2 | 2023 | 515 | 0.900 |
Why?
|
Globins | 4 | 2005 | 415 | 0.870 |
Why?
|
Plasma | 3 | 2020 | 573 | 0.810 |
Why?
|
Genome, Mitochondrial | 2 | 2018 | 71 | 0.770 |
Why?
|
Genetic Variation | 19 | 2019 | 6539 | 0.760 |
Why?
|
History, Ancient | 11 | 2019 | 210 | 0.760 |
Why?
|
Transcription Factor 7-Like 2 Protein | 2 | 2023 | 154 | 0.720 |
Why?
|
Diabetes Mellitus, Type 2 | 11 | 2024 | 11699 | 0.710 |
Why?
|
Genome-Wide Association Study | 12 | 2024 | 12178 | 0.710 |
Why?
|
Urine | 1 | 2020 | 370 | 0.670 |
Why?
|
Sphingomyelins | 1 | 2019 | 105 | 0.660 |
Why?
|
beta-Thalassemia | 4 | 2005 | 224 | 0.650 |
Why?
|
Diabetes Mellitus, Type 1 | 10 | 2013 | 3323 | 0.630 |
Why?
|
Genetic Predisposition to Disease | 18 | 2024 | 17384 | 0.570 |
Why?
|
Population Dynamics | 5 | 2018 | 300 | 0.560 |
Why?
|
Protein Kinase C-alpha | 1 | 2016 | 112 | 0.550 |
Why?
|
Women | 1 | 2018 | 230 | 0.540 |
Why?
|
Metabolomics | 6 | 2020 | 1460 | 0.540 |
Why?
|
Consanguinity | 6 | 2013 | 456 | 0.530 |
Why?
|
Phylogeny | 9 | 2018 | 2789 | 0.520 |
Why?
|
Alleles | 9 | 2024 | 6942 | 0.490 |
Why?
|
Cyclin-Dependent Kinase 5 | 1 | 2014 | 112 | 0.490 |
Why?
|
Demography | 1 | 2018 | 1650 | 0.440 |
Why?
|
Coronary Stenosis | 3 | 2021 | 836 | 0.430 |
Why?
|
Genome, Human | 11 | 2019 | 4419 | 0.420 |
Why?
|
Phylogeography | 6 | 2019 | 82 | 0.420 |
Why?
|
Respiratory Sounds | 1 | 2016 | 692 | 0.420 |
Why?
|
Syria | 4 | 2023 | 75 | 0.420 |
Why?
|
Aortic Valve | 1 | 2020 | 1900 | 0.380 |
Why?
|
Peptidyl-Dipeptidase A | 2 | 2010 | 364 | 0.360 |
Why?
|
Tumor Necrosis Factor-alpha | 3 | 2016 | 4400 | 0.360 |
Why?
|
Evolution, Molecular | 6 | 2020 | 1936 | 0.360 |
Why?
|
Cholesterol | 1 | 2019 | 2900 | 0.350 |
Why?
|
Polymorphism, Genetic | 7 | 2021 | 4332 | 0.350 |
Why?
|
Acculturation | 1 | 2010 | 181 | 0.340 |
Why?
|
Anemia, Sickle Cell | 2 | 2010 | 1015 | 0.340 |
Why?
|
Gene Frequency | 11 | 2017 | 3585 | 0.340 |
Why?
|
Gas Chromatography-Mass Spectrometry | 2 | 2020 | 361 | 0.340 |
Why?
|
Ectodysplasins | 1 | 2008 | 11 | 0.340 |
Why?
|
Middle East | 7 | 2016 | 219 | 0.340 |
Why?
|
Drug Resistance, Viral | 1 | 2014 | 829 | 0.330 |
Why?
|
RNA, Viral | 4 | 2014 | 2907 | 0.330 |
Why?
|
Aortic Valve Stenosis | 1 | 2020 | 1930 | 0.320 |
Why?
|
Communicable Diseases | 1 | 2016 | 873 | 0.320 |
Why?
|
Male | 67 | 2023 | 349022 | 0.310 |
Why?
|
Polymerase Chain Reaction | 7 | 2007 | 6174 | 0.310 |
Why?
|
Ectodermal Dysplasia | 1 | 2008 | 102 | 0.310 |
Why?
|
Humans | 115 | 2024 | 739398 | 0.300 |
Why?
|
Genetic Association Studies | 3 | 2017 | 2694 | 0.290 |
Why?
|
Genotype | 15 | 2017 | 12951 | 0.290 |
Why?
|
Risk Factors | 29 | 2024 | 71974 | 0.280 |
Why?
|
Archaeology | 2 | 2018 | 36 | 0.280 |
Why?
|
Pedigree | 4 | 2020 | 4640 | 0.280 |
Why?
|
Genetic Loci | 3 | 2023 | 2567 | 0.270 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2023 | 4220 | 0.270 |
Why?
|
Codon | 2 | 2008 | 613 | 0.260 |
Why?
|
Proteobacteria | 1 | 2005 | 45 | 0.260 |
Why?
|
Microsatellite Repeats | 5 | 2020 | 797 | 0.260 |
Why?
|
Gene Pool | 4 | 2019 | 35 | 0.250 |
Why?
|
Water Microbiology | 1 | 2005 | 117 | 0.240 |
Why?
|
Qb-SNARE Proteins | 1 | 2023 | 36 | 0.240 |
Why?
|
Genetic Testing | 4 | 2006 | 3441 | 0.240 |
Why?
|
Anti-Retroviral Agents | 1 | 2014 | 1734 | 0.240 |
Why?
|
DNA, Ribosomal | 1 | 2005 | 288 | 0.240 |
Why?
|
Water Supply | 1 | 2005 | 214 | 0.230 |
Why?
|
Fetal Hemoglobin | 2 | 2003 | 341 | 0.230 |
Why?
|
Mutation, Missense | 2 | 2014 | 2552 | 0.230 |
Why?
|
Chromosome Disorders | 1 | 2006 | 516 | 0.220 |
Why?
|
Seafood | 1 | 2006 | 379 | 0.220 |
Why?
|
Middle Aged | 33 | 2023 | 212863 | 0.220 |
Why?
|
Female | 51 | 2023 | 378853 | 0.220 |
Why?
|
Africa, Northern | 6 | 2019 | 82 | 0.220 |
Why?
|
Thalassemia | 1 | 2003 | 273 | 0.210 |
Why?
|
Hepatocyte Nuclear Factor 6 | 1 | 2021 | 9 | 0.210 |
Why?
|
China | 6 | 2022 | 2225 | 0.210 |
Why?
|
Adult | 39 | 2023 | 213394 | 0.200 |
Why?
|
Odds Ratio | 6 | 2021 | 9846 | 0.200 |
Why?
|
Lipoprotein(a) | 1 | 2005 | 424 | 0.200 |
Why?
|
Phenotype | 10 | 2017 | 16301 | 0.200 |
Why?
|
Antigens, Differentiation | 1 | 2004 | 925 | 0.200 |
Why?
|
Genetic Heterogeneity | 1 | 2005 | 727 | 0.200 |
Why?
|
Mediterranean Region | 2 | 2018 | 47 | 0.190 |
Why?
|
Mutation | 9 | 2013 | 29658 | 0.190 |
Why?
|
Cytochrome P-450 CYP3A | 1 | 2021 | 115 | 0.190 |
Why?
|
Geography | 5 | 2015 | 672 | 0.190 |
Why?
|
Africa | 5 | 2019 | 666 | 0.190 |
Why?
|
Nicotine | 1 | 2005 | 670 | 0.190 |
Why?
|
Spain | 2 | 2019 | 463 | 0.190 |
Why?
|
Fruit | 1 | 2006 | 1139 | 0.190 |
Why?
|
Cresols | 1 | 2020 | 28 | 0.190 |
Why?
|
Hepacivirus | 1 | 2007 | 1371 | 0.180 |
Why?
|
Coronary Restenosis | 1 | 2023 | 423 | 0.180 |
Why?
|
Promoter Regions, Genetic | 4 | 2014 | 5863 | 0.180 |
Why?
|
Rural Population | 4 | 2022 | 2181 | 0.180 |
Why?
|
DNA, Bacterial | 1 | 2005 | 1467 | 0.180 |
Why?
|
Nepovirus | 2 | 1996 | 2 | 0.180 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2006 | 2634 | 0.180 |
Why?
|
Asthma | 2 | 2016 | 5950 | 0.180 |
Why?
|
Europe | 10 | 2017 | 3331 | 0.170 |
Why?
|
Population Density | 3 | 2019 | 194 | 0.170 |
Why?
|
Cultural Characteristics | 1 | 2020 | 261 | 0.170 |
Why?
|
Smoking | 3 | 2017 | 8960 | 0.170 |
Why?
|
Tumor Virus Infections | 1 | 2002 | 452 | 0.170 |
Why?
|
Genetic Linkage | 5 | 2017 | 2433 | 0.170 |
Why?
|
Blood Glucose | 3 | 2020 | 6237 | 0.160 |
Why?
|
Bible | 1 | 2018 | 5 | 0.160 |
Why?
|
Delivery of Health Care | 1 | 2016 | 5272 | 0.160 |
Why?
|
Urinalysis | 1 | 2020 | 370 | 0.160 |
Why?
|
Age of Onset | 5 | 2013 | 3263 | 0.160 |
Why?
|
Methylenetetrahydrofolate Reductase (NADPH2) | 3 | 2012 | 285 | 0.160 |
Why?
|
Uterine Cervical Dysplasia | 1 | 2002 | 386 | 0.160 |
Why?
|
Italy | 2 | 2018 | 827 | 0.160 |
Why?
|
Influenza in Birds | 1 | 2018 | 74 | 0.150 |
Why?
|
Asia | 6 | 2017 | 604 | 0.150 |
Why?
|
Hepatitis C | 1 | 2007 | 1580 | 0.150 |
Why?
|
Chromosomes, Human, X | 2 | 2016 | 296 | 0.150 |
Why?
|
Leptin | 2 | 2002 | 1589 | 0.150 |
Why?
|
Case-Control Studies | 7 | 2021 | 21694 | 0.150 |
Why?
|
Adolescent | 15 | 2019 | 85405 | 0.150 |
Why?
|
Exons | 3 | 2008 | 2430 | 0.150 |
Why?
|
Influenza A Virus, H5N1 Subtype | 1 | 2018 | 112 | 0.150 |
Why?
|
Prenatal Diagnosis | 1 | 2004 | 1227 | 0.140 |
Why?
|
Tunisia | 1 | 2016 | 33 | 0.140 |
Why?
|
Cyprus | 1 | 2016 | 77 | 0.140 |
Why?
|
Medical Records | 1 | 2002 | 1413 | 0.140 |
Why?
|
Periodontitis | 1 | 2021 | 549 | 0.140 |
Why?
|
Influenza, Human | 2 | 2018 | 1476 | 0.140 |
Why?
|
Thromboembolism | 1 | 2003 | 984 | 0.140 |
Why?
|
Osteoporosis | 2 | 2022 | 1576 | 0.140 |
Why?
|
Factor V | 2 | 2010 | 174 | 0.140 |
Why?
|
Recombination, Genetic | 2 | 2011 | 1591 | 0.140 |
Why?
|
Tooth | 1 | 2018 | 205 | 0.140 |
Why?
|
Myocardial Infarction | 1 | 2017 | 11668 | 0.140 |
Why?
|
HIV-1 | 1 | 2014 | 6931 | 0.140 |
Why?
|
Cytochrome P-450 CYP1A2 | 1 | 2015 | 68 | 0.140 |
Why?
|
HLA-DQ Antigens | 3 | 2009 | 210 | 0.130 |
Why?
|
Sentinel Surveillance | 1 | 2018 | 291 | 0.130 |
Why?
|
Viral Core Proteins | 1 | 1996 | 161 | 0.130 |
Why?
|
Chickens | 1 | 2018 | 864 | 0.130 |
Why?
|
Africa South of the Sahara | 3 | 2019 | 727 | 0.130 |
Why?
|
Constriction, Pathologic | 3 | 2023 | 1096 | 0.130 |
Why?
|
Bone Density | 2 | 2022 | 3471 | 0.130 |
Why?
|
Lipoproteins, LDL | 1 | 2019 | 626 | 0.130 |
Why?
|
Prevalence | 7 | 2014 | 15153 | 0.130 |
Why?
|
Papillomaviridae | 1 | 2002 | 1117 | 0.130 |
Why?
|
Dyslipidemias | 1 | 2023 | 851 | 0.130 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2021 | 1125 | 0.130 |
Why?
|
Aged | 23 | 2024 | 162698 | 0.130 |
Why?
|
Arabs | 1 | 2017 | 177 | 0.130 |
Why?
|
tRNA Methyltransferases | 1 | 2014 | 53 | 0.130 |
Why?
|
Pancreas | 1 | 2021 | 1678 | 0.120 |
Why?
|
Coronary Angiography | 3 | 2015 | 4560 | 0.120 |
Why?
|
Polymorphism, Restriction Fragment Length | 3 | 2005 | 769 | 0.120 |
Why?
|
Lipoproteins, HDL | 1 | 2019 | 643 | 0.120 |
Why?
|
Cholesterol, LDL | 3 | 2019 | 2334 | 0.120 |
Why?
|
Reverse Transcription | 1 | 2014 | 46 | 0.120 |
Why?
|
Leukemia-Lymphoma, Adult T-Cell | 2 | 2007 | 166 | 0.120 |
Why?
|
HIV Protease | 1 | 2014 | 96 | 0.120 |
Why?
|
Amyloidosis, Familial | 1 | 2013 | 13 | 0.120 |
Why?
|
Culture | 1 | 2018 | 627 | 0.120 |
Why?
|
Bioartificial Organs | 1 | 2013 | 49 | 0.120 |
Why?
|
Alstrom Syndrome | 1 | 2013 | 11 | 0.110 |
Why?
|
Cultural Evolution | 1 | 2013 | 9 | 0.110 |
Why?
|
Cluster Analysis | 4 | 2016 | 2711 | 0.110 |
Why?
|
HIV Reverse Transcriptase | 1 | 2014 | 215 | 0.110 |
Why?
|
Hyperglycemia | 1 | 2021 | 1357 | 0.110 |
Why?
|
Corneal Dystrophies, Hereditary | 1 | 2013 | 80 | 0.110 |
Why?
|
Sequence Analysis, DNA | 4 | 2014 | 4791 | 0.110 |
Why?
|
Base Sequence | 7 | 2017 | 12804 | 0.110 |
Why?
|
Regression Analysis | 2 | 2020 | 6452 | 0.110 |
Why?
|
Chi-Square Distribution | 3 | 2010 | 3510 | 0.100 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2014 | 379 | 0.100 |
Why?
|
Heart Valve Prosthesis | 1 | 2020 | 1479 | 0.100 |
Why?
|
Young Adult | 10 | 2021 | 56255 | 0.100 |
Why?
|
Principal Component Analysis | 4 | 2017 | 937 | 0.100 |
Why?
|
Hyperhomocysteinemia | 1 | 2012 | 124 | 0.100 |
Why?
|
Mass Spectrometry | 1 | 2019 | 2200 | 0.100 |
Why?
|
Membrane Proteins | 1 | 2008 | 7862 | 0.100 |
Why?
|
Caffeine | 1 | 2015 | 697 | 0.100 |
Why?
|
Genes, Transgenic, Suicide | 1 | 2010 | 30 | 0.100 |
Why?
|
Genetic Markers | 2 | 2008 | 2630 | 0.100 |
Why?
|
Interferon-alpha | 2 | 2007 | 895 | 0.090 |
Why?
|
Biological Evolution | 2 | 2015 | 1072 | 0.090 |
Why?
|
Respiratory Tract Infections | 1 | 2018 | 956 | 0.090 |
Why?
|
Fertility Agents, Female | 1 | 2010 | 99 | 0.090 |
Why?
|
Inflammation | 2 | 2023 | 10534 | 0.090 |
Why?
|
Mortality | 1 | 2021 | 2851 | 0.090 |
Why?
|
Milk | 2 | 2003 | 447 | 0.090 |
Why?
|
Papillomavirus Infections | 1 | 2002 | 1585 | 0.090 |
Why?
|
Population Groups | 1 | 2010 | 207 | 0.090 |
Why?
|
Cost of Illness | 2 | 2018 | 1849 | 0.090 |
Why?
|
Mediterranean Sea | 1 | 2008 | 12 | 0.090 |
Why?
|
Infection Control | 1 | 2016 | 968 | 0.090 |
Why?
|
Tandem Repeat Sequences | 2 | 2009 | 186 | 0.080 |
Why?
|
Child | 11 | 2018 | 77033 | 0.080 |
Why?
|
Chromosome Mapping | 2 | 2015 | 4743 | 0.080 |
Why?
|
Plasminogen Activator Inhibitor 1 | 1 | 2010 | 281 | 0.080 |
Why?
|
Child, Preschool | 8 | 2018 | 40802 | 0.080 |
Why?
|
Wolfram Syndrome | 1 | 2008 | 13 | 0.080 |
Why?
|
Stroke | 2 | 2022 | 9898 | 0.080 |
Why?
|
Prosthesis Implantation | 1 | 2013 | 640 | 0.080 |
Why?
|
Homocysteine | 1 | 2012 | 647 | 0.080 |
Why?
|
Body Height | 1 | 2015 | 1577 | 0.080 |
Why?
|
Cohort Studies | 6 | 2022 | 40389 | 0.080 |
Why?
|
Disease Outbreaks | 1 | 2018 | 1779 | 0.080 |
Why?
|
Protein Isoforms | 1 | 2013 | 1725 | 0.080 |
Why?
|
Streptococcus agalactiae | 1 | 2010 | 373 | 0.080 |
Why?
|
Diet | 1 | 2006 | 7876 | 0.080 |
Why?
|
Echocardiography | 1 | 2020 | 5098 | 0.080 |
Why?
|
Drug Costs | 1 | 2016 | 1115 | 0.080 |
Why?
|
Cross-Sectional Studies | 7 | 2020 | 24714 | 0.080 |
Why?
|
Isotretinoin | 1 | 2008 | 111 | 0.080 |
Why?
|
Health Services Needs and Demand | 1 | 2016 | 1409 | 0.080 |
Why?
|
Brucellosis | 1 | 2007 | 19 | 0.080 |
Why?
|
Behcet Syndrome | 1 | 2008 | 86 | 0.080 |
Why?
|
HIV Infections | 1 | 2014 | 16764 | 0.080 |
Why?
|
Histocytological Preparation Techniques | 1 | 2007 | 30 | 0.080 |
Why?
|
Biotinidase Deficiency | 1 | 2006 | 3 | 0.070 |
Why?
|
RNA-Binding Proteins | 1 | 1996 | 1890 | 0.070 |
Why?
|
Multivariate Analysis | 1 | 2020 | 12237 | 0.070 |
Why?
|
Microfilament Proteins | 1 | 2012 | 1150 | 0.070 |
Why?
|
HTLV-I Infections | 1 | 2007 | 101 | 0.070 |
Why?
|
B-Lymphocytes | 1 | 2020 | 4663 | 0.070 |
Why?
|
Human T-lymphotropic virus 1 | 1 | 2007 | 140 | 0.070 |
Why?
|
Microbiological Techniques | 1 | 2007 | 101 | 0.070 |
Why?
|
Glomerulonephritis, IGA | 1 | 2006 | 66 | 0.070 |
Why?
|
Heterozygote | 3 | 2016 | 2798 | 0.070 |
Why?
|
Reproductive Techniques, Assisted | 1 | 2010 | 483 | 0.070 |
Why?
|
Language | 2 | 2015 | 1447 | 0.070 |
Why?
|
Chromosomes, Human, Pair 21 | 1 | 2006 | 230 | 0.070 |
Why?
|
Chromosomes, Human, Pair 13 | 1 | 2006 | 198 | 0.070 |
Why?
|
Antigens, CD | 2 | 2008 | 4024 | 0.070 |
Why?
|
Chromosomes, Human, Pair 18 | 1 | 2006 | 245 | 0.070 |
Why?
|
Albinism, Oculocutaneous | 1 | 2005 | 17 | 0.070 |
Why?
|
Streptococcal Infections | 1 | 2010 | 635 | 0.070 |
Why?
|
Monophenol Monooxygenase | 1 | 2005 | 70 | 0.070 |
Why?
|
Proviruses | 1 | 2007 | 316 | 0.060 |
Why?
|
Logistic Models | 4 | 2016 | 13402 | 0.060 |
Why?
|
Cotinine | 1 | 2005 | 205 | 0.060 |
Why?
|
Risk Assessment | 4 | 2016 | 23294 | 0.060 |
Why?
|
Algorithms | 3 | 2019 | 13872 | 0.060 |
Why?
|
Hypertension | 3 | 2021 | 8431 | 0.060 |
Why?
|
Zidovudine | 1 | 2007 | 623 | 0.060 |
Why?
|
Dermatologic Agents | 1 | 2008 | 274 | 0.060 |
Why?
|
Quantitative Trait Loci | 1 | 2012 | 2016 | 0.060 |
Why?
|
Infant | 6 | 2021 | 34923 | 0.060 |
Why?
|
Iran | 3 | 2015 | 700 | 0.060 |
Why?
|
Insurance Coverage | 1 | 2016 | 1891 | 0.060 |
Why?
|
Ethiopia | 2 | 2016 | 490 | 0.060 |
Why?
|
NF-kappa B | 2 | 2010 | 2502 | 0.060 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 2005 | 1088 | 0.060 |
Why?
|
Depression | 1 | 2023 | 7689 | 0.060 |
Why?
|
Oligonucleotide Probes | 1 | 2004 | 425 | 0.060 |
Why?
|
Hemoglobin A2 | 1 | 2003 | 5 | 0.060 |
Why?
|
Blood Protein Electrophoresis | 1 | 2003 | 73 | 0.060 |
Why?
|
Health Personnel | 1 | 2016 | 3203 | 0.060 |
Why?
|
Hemoglobin A | 1 | 2003 | 87 | 0.060 |
Why?
|
Family Health | 2 | 2010 | 1281 | 0.060 |
Why?
|
alpha-Thalassemia | 1 | 2003 | 46 | 0.060 |
Why?
|
Health Expenditures | 1 | 2016 | 2348 | 0.060 |
Why?
|
Birth Order | 1 | 2003 | 95 | 0.050 |
Why?
|
Spasms, Infantile | 1 | 2006 | 301 | 0.050 |
Why?
|
Homozygote | 2 | 2004 | 1788 | 0.050 |
Why?
|
Arsenicals | 1 | 2003 | 124 | 0.050 |
Why?
|
Health | 1 | 2005 | 390 | 0.050 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2007 | 4743 | 0.050 |
Why?
|
Hypereosinophilic Syndrome | 1 | 2003 | 93 | 0.050 |
Why?
|
Coronary Disease | 1 | 2017 | 6068 | 0.050 |
Why?
|
Syndrome | 1 | 2008 | 3241 | 0.050 |
Why?
|
Receptors, CCR5 | 1 | 2004 | 497 | 0.050 |
Why?
|
Linkage Disequilibrium | 2 | 2017 | 1992 | 0.050 |
Why?
|
Diabetes Mellitus | 1 | 2020 | 5702 | 0.050 |
Why?
|
Streptozocin | 1 | 2021 | 191 | 0.050 |
Why?
|
Molecular Sequence Data | 4 | 2015 | 18125 | 0.050 |
Why?
|
Anthropometry | 1 | 2006 | 1344 | 0.050 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2005 | 946 | 0.050 |
Why?
|
Drinking | 1 | 2002 | 197 | 0.050 |
Why?
|
Oxides | 1 | 2003 | 404 | 0.050 |
Why?
|
Aged, 80 and over | 4 | 2019 | 57650 | 0.050 |
Why?
|
Point Mutation | 1 | 2006 | 1626 | 0.050 |
Why?
|
Aspartate Aminotransferases | 1 | 2022 | 418 | 0.050 |
Why?
|
Species Specificity | 1 | 2005 | 2480 | 0.050 |
Why?
|
Antiviral Agents | 2 | 2018 | 2971 | 0.050 |
Why?
|
Y Chromosome | 1 | 2001 | 206 | 0.050 |
Why?
|
Graft Rejection | 1 | 2013 | 4379 | 0.050 |
Why?
|
Comorbidity | 1 | 2014 | 10362 | 0.050 |
Why?
|
Models, Genetic | 3 | 2017 | 3493 | 0.050 |
Why?
|
Absorptiometry, Photon | 1 | 2006 | 1726 | 0.050 |
Why?
|
Mutagenesis, Insertional | 1 | 2003 | 656 | 0.050 |
Why?
|
Autoantibodies | 1 | 2008 | 2020 | 0.050 |
Why?
|
Gallbladder | 1 | 2021 | 300 | 0.050 |
Why?
|
Organogenesis | 1 | 2021 | 223 | 0.050 |
Why?
|
Cardiovascular Diseases | 1 | 2005 | 15070 | 0.040 |
Why?
|
Obesity | 2 | 2020 | 12643 | 0.040 |
Why?
|
Fossils | 1 | 2019 | 75 | 0.040 |
Why?
|
Nutrition Surveys | 1 | 2006 | 1645 | 0.040 |
Why?
|
Multigene Family | 1 | 2003 | 1107 | 0.040 |
Why?
|
Pancreatic Diseases | 1 | 2021 | 350 | 0.040 |
Why?
|
Fasting | 1 | 2005 | 1587 | 0.040 |
Why?
|
Fabaceae | 2 | 1996 | 103 | 0.040 |
Why?
|
Vaginal Smears | 1 | 2002 | 512 | 0.040 |
Why?
|
Plants, Medicinal | 2 | 1996 | 167 | 0.040 |
Why?
|
Body Mass Index | 3 | 2021 | 12655 | 0.040 |
Why?
|
Premature Birth | 1 | 2010 | 1702 | 0.040 |
Why?
|
Hospitalization | 1 | 2018 | 10208 | 0.040 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2010 | 2028 | 0.040 |
Why?
|
Sex Distribution | 1 | 2003 | 2296 | 0.040 |
Why?
|
Proteins | 1 | 2013 | 6082 | 0.040 |
Why?
|
Oseltamivir | 1 | 2018 | 75 | 0.040 |
Why?
|
Fetal Growth Retardation | 1 | 2021 | 570 | 0.040 |
Why?
|
Influenza A Virus, H3N2 Subtype | 1 | 2018 | 89 | 0.040 |
Why?
|
Vitamin B 12 | 1 | 2020 | 527 | 0.040 |
Why?
|
Triglycerides | 2 | 2015 | 2447 | 0.040 |
Why?
|
Chad | 1 | 2016 | 8 | 0.040 |
Why?
|
Seasons | 1 | 2003 | 1486 | 0.040 |
Why?
|
Postmenopause | 1 | 2006 | 2456 | 0.040 |
Why?
|
Reproducibility of Results | 3 | 2017 | 19811 | 0.040 |
Why?
|
Creatinine | 1 | 2022 | 1903 | 0.040 |
Why?
|
Morbidity | 1 | 2022 | 1763 | 0.040 |
Why?
|
Pilot Projects | 2 | 2018 | 8275 | 0.040 |
Why?
|
Animals | 8 | 2021 | 168368 | 0.040 |
Why?
|
HLA Antigens | 1 | 2002 | 1382 | 0.040 |
Why?
|
Congenital Abnormalities | 1 | 2021 | 708 | 0.040 |
Why?
|
Ribonuclease H | 1 | 1996 | 44 | 0.040 |
Why?
|
Greece | 1 | 2017 | 343 | 0.040 |
Why?
|
Blood Transfusion | 1 | 2003 | 1296 | 0.040 |
Why?
|
Armenia | 1 | 2015 | 17 | 0.030 |
Why?
|
Probability | 1 | 2002 | 2500 | 0.030 |
Why?
|
Neoplasms | 2 | 2016 | 21507 | 0.030 |
Why?
|
Databases, Genetic | 2 | 2014 | 1777 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2007 | 3504 | 0.030 |
Why?
|
Age Distribution | 1 | 2002 | 2904 | 0.030 |
Why?
|
Cytochrome P-450 CYP1A1 | 1 | 2015 | 88 | 0.030 |
Why?
|
Nasopharynx | 1 | 2018 | 378 | 0.030 |
Why?
|
Aryldialkylphosphatase | 1 | 2015 | 63 | 0.030 |
Why?
|
DNA Mutational Analysis | 1 | 2004 | 4182 | 0.030 |
Why?
|
Sex Factors | 2 | 2015 | 10398 | 0.030 |
Why?
|
DNA, Viral | 1 | 2002 | 2223 | 0.030 |
Why?
|
Breast Feeding | 1 | 2003 | 1334 | 0.030 |
Why?
|
Severity of Illness Index | 2 | 2010 | 15511 | 0.030 |
Why?
|
Retrospective Studies | 3 | 2022 | 76631 | 0.030 |
Why?
|
Oligodeoxyribonucleotides | 1 | 1996 | 708 | 0.030 |
Why?
|
Dyspnea | 1 | 2022 | 1295 | 0.030 |
Why?
|
Pluripotent Stem Cells | 1 | 2021 | 791 | 0.030 |
Why?
|
Rats | 2 | 2021 | 24270 | 0.030 |
Why?
|
Multifactorial Inheritance | 1 | 2021 | 1174 | 0.030 |
Why?
|
Mass Screening | 1 | 2010 | 5265 | 0.030 |
Why?
|
Data Interpretation, Statistical | 1 | 2004 | 2716 | 0.030 |
Why?
|
Influenza A Virus, H1N1 Subtype | 1 | 2018 | 459 | 0.030 |
Why?
|
Diabetic Nephropathies | 1 | 2001 | 981 | 0.030 |
Why?
|
Diabetes Insipidus, Neurogenic | 1 | 2013 | 19 | 0.030 |
Why?
|
Leukotrienes | 1 | 2015 | 255 | 0.030 |
Why?
|
Cytochrome P-450 Enzyme System | 1 | 2016 | 419 | 0.030 |
Why?
|
Ketosis | 1 | 2013 | 49 | 0.030 |
Why?
|
Agriculture | 1 | 2014 | 186 | 0.030 |
Why?
|
Primary Prevention | 1 | 2020 | 1165 | 0.030 |
Why?
|
Workflow | 1 | 2017 | 831 | 0.030 |
Why?
|
Inflammation Mediators | 1 | 2021 | 1890 | 0.030 |
Why?
|
Lumbar Vertebrae | 1 | 2022 | 1843 | 0.030 |
Why?
|
Incidence | 3 | 2010 | 20913 | 0.030 |
Why?
|
Antineoplastic Agents | 1 | 2016 | 13635 | 0.030 |
Why?
|
Morocco | 1 | 2012 | 28 | 0.030 |
Why?
|
Meta-Analysis as Topic | 1 | 2017 | 1339 | 0.030 |
Why?
|
Afghanistan | 1 | 2012 | 79 | 0.030 |
Why?
|
Piperazines | 1 | 2003 | 2480 | 0.030 |
Why?
|
Asia, Central | 1 | 2011 | 12 | 0.030 |
Why?
|
Systems Biology | 1 | 2016 | 471 | 0.030 |
Why?
|
Homeodomain Proteins | 1 | 2021 | 2409 | 0.030 |
Why?
|
Vitamins | 1 | 2020 | 1602 | 0.030 |
Why?
|
Asia, Southeastern | 1 | 2011 | 111 | 0.030 |
Why?
|
Software | 1 | 2006 | 4423 | 0.030 |
Why?
|
Enzyme Inhibitors | 1 | 2003 | 3802 | 0.030 |
Why?
|
Markov Chains | 1 | 2015 | 970 | 0.030 |
Why?
|
Pregnancy | 3 | 2010 | 29002 | 0.030 |
Why?
|
Lens, Crystalline | 1 | 2013 | 386 | 0.030 |
Why?
|
Health Surveys | 1 | 2002 | 4022 | 0.030 |
Why?
|
Organic Anion Transporters | 1 | 2012 | 100 | 0.020 |
Why?
|
Flucytosine | 1 | 2010 | 33 | 0.020 |
Why?
|
Overweight | 1 | 2022 | 2355 | 0.020 |
Why?
|
Infectious Disease Transmission, Vertical | 2 | 2010 | 1331 | 0.020 |
Why?
|
Coffee | 1 | 2015 | 577 | 0.020 |
Why?
|
Genome | 1 | 2019 | 1794 | 0.020 |
Why?
|
Renin-Angiotensin System | 1 | 2016 | 763 | 0.020 |
Why?
|
Linguistics | 1 | 2011 | 96 | 0.020 |
Why?
|
Internationality | 1 | 2016 | 1004 | 0.020 |
Why?
|
Infant, Newborn | 3 | 2021 | 25470 | 0.020 |
Why?
|
Pyrimidines | 1 | 2003 | 2918 | 0.020 |
Why?
|
Russia | 1 | 2011 | 409 | 0.020 |
Why?
|
Turkey | 1 | 2010 | 234 | 0.020 |
Why?
|
Structure-Activity Relationship | 1 | 1996 | 3146 | 0.020 |
Why?
|
DNA | 1 | 2004 | 7275 | 0.020 |
Why?
|
Hypoglycemic Agents | 1 | 2002 | 2861 | 0.020 |
Why?
|
Hyperlipidemias | 1 | 2015 | 785 | 0.020 |
Why?
|
Adipose Tissue | 1 | 2002 | 3280 | 0.020 |
Why?
|
Lipids | 1 | 2021 | 3307 | 0.020 |
Why?
|
Corneal Transplantation | 1 | 2013 | 368 | 0.020 |
Why?
|
Serotyping | 1 | 2010 | 339 | 0.020 |
Why?
|
Bayes Theorem | 1 | 2017 | 2303 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2021 | 38942 | 0.020 |
Why?
|
Protons | 1 | 2015 | 1124 | 0.020 |
Why?
|
Data Mining | 1 | 2014 | 536 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2005 | 15036 | 0.020 |
Why?
|
Fetal Membranes, Premature Rupture | 1 | 2010 | 139 | 0.020 |
Why?
|
Diuretics | 1 | 2012 | 590 | 0.020 |
Why?
|
Homeostasis | 1 | 2020 | 3348 | 0.020 |
Why?
|
Obstetric Labor, Premature | 1 | 2010 | 282 | 0.020 |
Why?
|
Lentivirus | 1 | 2010 | 501 | 0.020 |
Why?
|
Pain | 1 | 2003 | 4923 | 0.020 |
Why?
|
Insulin | 1 | 2002 | 6569 | 0.020 |
Why?
|
Genomics | 2 | 2015 | 5652 | 0.020 |
Why?
|
Transcription, Genetic | 1 | 2021 | 7709 | 0.020 |
Why?
|
Acute Disease | 1 | 2018 | 7128 | 0.020 |
Why?
|
Cell Adhesion Molecules | 1 | 2013 | 1599 | 0.020 |
Why?
|
Prospective Studies | 2 | 2022 | 53037 | 0.020 |
Why?
|
Virus Replication | 1 | 1995 | 2529 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2003 | 9387 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2010 | 2084 | 0.020 |
Why?
|
3' Untranslated Regions | 1 | 2008 | 508 | 0.020 |
Why?
|
Prostheses and Implants | 1 | 2013 | 1383 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2011 | 2881 | 0.020 |
Why?
|
Coronary Vessels | 1 | 2017 | 3097 | 0.020 |
Why?
|
Time Factors | 3 | 2017 | 40050 | 0.020 |
Why?
|
Antigens, Neoplasm | 1 | 2013 | 1977 | 0.020 |
Why?
|
Neonatal Screening | 1 | 2010 | 591 | 0.020 |
Why?
|
Hematuria | 1 | 2006 | 234 | 0.020 |
Why?
|
RNA | 1 | 1995 | 2723 | 0.020 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2015 | 3757 | 0.020 |
Why?
|
Visual Acuity | 1 | 2013 | 2517 | 0.020 |
Why?
|
Siblings | 1 | 2009 | 853 | 0.020 |
Why?
|
Enzyme Activation | 1 | 2010 | 3701 | 0.020 |
Why?
|
Cell Differentiation | 1 | 2021 | 11460 | 0.020 |
Why?
|
Diabetic Retinopathy | 1 | 2013 | 1203 | 0.010 |
Why?
|
Mice, Nude | 1 | 2010 | 3692 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2020 | 10455 | 0.010 |
Why?
|
Gene Regulatory Networks | 1 | 2012 | 1706 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 1996 | 13816 | 0.010 |
Why?
|
HIV Seronegativity | 1 | 2004 | 209 | 0.010 |
Why?
|
Gene Products, tax | 1 | 2003 | 51 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2010 | 20676 | 0.010 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2015 | 3571 | 0.010 |
Why?
|
Computational Biology | 1 | 2015 | 3506 | 0.010 |
Why?
|
Internet | 1 | 2015 | 3048 | 0.010 |
Why?
|
Pandemics | 1 | 2022 | 8274 | 0.010 |
Why?
|
Frameshift Mutation | 1 | 2004 | 398 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2003 | 11410 | 0.010 |
Why?
|
Blood Donors | 1 | 2004 | 357 | 0.010 |
Why?
|
Receptor, Platelet-Derived Growth Factor beta | 1 | 2003 | 188 | 0.010 |
Why?
|
Gestational Age | 1 | 2010 | 3486 | 0.010 |
Why?
|
Trisomy | 1 | 2003 | 264 | 0.010 |
Why?
|
Cell Cycle Proteins | 1 | 2013 | 3433 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2017 | 19220 | 0.010 |
Why?
|
Infant, Premature | 1 | 2010 | 2039 | 0.010 |
Why?
|
Chromosomes, Human, Pair 8 | 1 | 2003 | 463 | 0.010 |
Why?
|
Karyotyping | 1 | 2003 | 1241 | 0.010 |
Why?
|
Fusion Proteins, bcr-abl | 1 | 2003 | 427 | 0.010 |
Why?
|
Cysteine Endopeptidases | 1 | 2003 | 561 | 0.010 |
Why?
|
Pregnancy Outcome | 1 | 2010 | 2789 | 0.010 |
Why?
|
Hospitals, Teaching | 1 | 2004 | 1166 | 0.010 |
Why?
|
Insulin Resistance | 1 | 2013 | 3858 | 0.010 |
Why?
|
Mice | 2 | 2020 | 81002 | 0.010 |
Why?
|
Leukocyte Count | 1 | 2003 | 1581 | 0.010 |
Why?
|
Evidence-Based Medicine | 1 | 2010 | 3606 | 0.010 |
Why?
|
Cell Line | 1 | 2012 | 15987 | 0.010 |
Why?
|
DNA Primers | 1 | 2003 | 2893 | 0.010 |
Why?
|
Viral Load | 1 | 2007 | 3299 | 0.010 |
Why?
|
Benzamides | 1 | 2003 | 1374 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2010 | 7726 | 0.010 |
Why?
|
Albuminuria | 1 | 2001 | 692 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2007 | 6478 | 0.010 |
Why?
|
Gene Deletion | 1 | 2004 | 2757 | 0.010 |
Why?
|
RNA, Satellite | 1 | 1995 | 16 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2004 | 6370 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 2003 | 6310 | 0.010 |
Why?
|
Biopsy | 1 | 2006 | 6722 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2002 | 4935 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2010 | 16646 | 0.010 |
Why?
|
Kidney Failure, Chronic | 1 | 2006 | 2546 | 0.010 |
Why?
|
Population Surveillance | 1 | 2004 | 2629 | 0.010 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2003 | 2455 | 0.010 |
Why?
|
Virion | 1 | 1995 | 435 | 0.010 |
Why?
|
Cell Survival | 1 | 2003 | 5877 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2007 | 14740 | 0.010 |
Why?
|
Nucleic Acid Conformation | 1 | 1995 | 913 | 0.010 |
Why?
|
Prognosis | 1 | 2006 | 28901 | 0.000 |
Why?
|
Treatment Outcome | 1 | 2007 | 62693 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 2006 | 35326 | 0.000 |
Why?
|